SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 59 of 100
Health
Johnson & Johnson Is Dialing Down Crazy Drug Price Hikes
By
Sy Mukherjee
February 27, 2017
Leadership
Democrats Must Overhaul Party, Attack Big Business, Sanders Says
By
Reuters
February 26, 2017
Health
Pre-existing Conditions Complicate Health Care Replacement
By
The Associated Press
February 25, 2017
Health
These Were the 10 Biggest Pharmaceutical Deals of 2016
By
Sy Mukherjee
February 24, 2017
Health
Gilead Just Paid $125 Million to Nab a Big Market Advantage
By
Sy Mukherjee
February 21, 2017
Health
Martin Shkreli’s Harvard Talk Got Disrupted by a Fire Alarm and Protests
By
Sy Mukherjee
February 16, 2017
Finance
How Sanofi Lost Out to J&J in the $30 Billion Battle for Actelion
By
Reuters
February 16, 2017
Health
Drug Company Hits Pause on Launching an $89,000 Muscular Dystrophy Drug After Backlash
By
Sy Mukherjee
February 13, 2017
Health
Allergan Will Buy Zeltiq for $2.48 Billion
By
Reuters
February 13, 2017
Health
This Pharma Company Is Selling a Decades-old Drug to Treat Muscular Dystrophy for $89,000
By
Sy Mukherjee
February 10, 2017
Retail
CVS Health Says it Is Not to Blame For Skyrocketing Drug Costs
By
Phil Wahba
February 9, 2017
Health
Mylan’s EpiPen Competitor Is Also Under Fire for Drug Price Hikes
By
Sy Mukherjee
February 8, 2017
Health
Teva Pharmaceuticals CEO Vigodman Is Stepping Down
By
Reuters
February 7, 2017
Commentary
Why Big Pharma Should Think Twice About Working With Trump
By
Pierre Azoulay
February 6, 2017
Leadership
This Big Pharma CEO Thinks Trump’s Drug Pricing Threats Are All Bark and No Bite
By
Sy Mukherjee
February 2, 2017
Most Popular
Economy
Jerome Powell says the Gen Z hiring nightmare is real: 'Kids coming out of college...are having a hard time finding...
By
Nick Lichtenberg
Banking
Markets expected the rate cut, but the ‘real surprise’ is the Fed’s opinion on the current state of the economy, quant...
By
Amanda Gerut
Law
Publishers Clearing House, company that promised 'forever' payments to sweepstakes winners, says actually nevermind
By
The Associated Press